Optimal strategy for chronic hepatitis B patients receiving nucleos(t)ide analogue antiviral treatment.
- Author:
Hui ZHUANG
1
;
Xin-Hua WENG
Author Information
1. Department of Microbiology, Peking University Health Science Center, Beijing 100191, China. zhuangbmu@126.com
- Publication Type:Journal Article
- MeSH:
Antiviral Agents;
administration & dosage;
therapeutic use;
Hepatitis B, Chronic;
drug therapy;
Humans;
Nucleotides;
administration & dosage;
therapeutic use
- From:
Chinese Journal of Hepatology
2011;19(6):408-411
- CountryChina
- Language:Chinese
